down arrow

Dr Lalchand. Lab

  • Market Cap: Micro Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE871Z01013
  • NSEID:
  • BSEID: 541299
INR
11.75
0.01 (0.09%)
BSENSE

Apr 11, 12:33 PM

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.0 k (-37.50%) Volume

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

57.18%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 5 Cr (Micro Cap)

stock-summary
P/E

5.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.11

stock-summary
Return on Equity

6.50%

stock-summary
Price to Book

0.53

Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-42.68%
0%
-42.68%
1 Year
-46.35%
0%
-46.35%
2 Years
-58.64%
0%
-58.64%
3 Years
-67.81%
0%
-67.81%
4 Years
-15.47%
0%
-15.47%
5 Years
28.98%
0%
28.98%

Dr Lalchand. Lab for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-1.80%
EBIT Growth (5y)
-1.65%
EBIT to Interest (avg)
0.93
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.94
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.97%
ROE (avg)
11.59%
Valuation key factors
Factor
Value
P/E Ratio
5
Industry P/E
55
Price to Book Value
0.53
EV to EBIT
6.12
EV to EBITDA
4.40
EV to Capital Employed
0.58
EV to Sales
1.27
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
7.28%
ROE (Latest)
6.50%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Arjan Lal Chandani (51.48%)

Highest Public shareholder

Amit Charan (5.08%)

Individual Investors Holdings

36.54%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Dr Lalchand. Lab"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 2.40% vs -23.81% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -78.87% vs 888.89% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.13",
          "val2": "2.08",
          "chgp": "2.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.54",
          "val2": "1.03",
          "chgp": "-47.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.28",
          "chgp": "-82.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.15",
          "val2": "0.71",
          "chgp": "-78.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.35%",
          "val2": "49.52%",
          "chgp": "-24.17%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Dr Lalchand. Lab"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -4.56% vs -55.32% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 139.74% vs -267.74% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.81",
          "val2": "5.04",
          "chgp": "-4.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.39",
          "val2": "0.09",
          "chgp": "1,444.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.38",
          "val2": "0.99",
          "chgp": "-61.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.62",
          "val2": "-1.56",
          "chgp": "139.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.90%",
          "val2": "1.79%",
          "chgp": "27.11%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Mar'24
Change(%)
Net Sales
2.13
2.08
2.40%
Operating Profit (PBDIT) excl Other Income
0.54
1.03
-47.57%
Interest
0.05
0.28
-82.14%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.15
0.71
-78.87%
Operating Profit Margin (Excl OI)
25.35%
49.52%
-24.17%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 2.40% vs -23.81% in Mar 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -78.87% vs 888.89% in Mar 2024

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
4.81
5.04
-4.56%
Operating Profit (PBDIT) excl Other Income
1.39
0.09
1,444.44%
Interest
0.38
0.99
-61.62%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.62
-1.56
139.74%
Operating Profit Margin (Excl OI)
28.90%
1.79%
27.11%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -4.56% vs -55.32% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 139.74% vs -267.74% in Mar 2023

stock-summaryCompany CV
About Dr Lalchandani Labs Ltd stock-summary
stock-summary
Dr Lalchandani Labs Ltd
Micro Cap
Hospital & Healthcare Services
Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of "Dr.
Company Coordinates stock-summary
Company Details
M-20 Basement, Greater Kailash-1 New Delhi New Delhi : 110048
stock-summary
Tel: 91-11-49057058
stock-summary
info@lalchandanipathlab.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai